North America Blood Plasma Derivatives Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, and Others), Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, von Willebrand’s Diseases, and Others), and End User (Hospitals, Clinics, and Others)
The North America blood plasma derivatives market was valued at US$ 11,821.24 million in 2022 and is projected to reach US$ 20,447.70 million by 2028; it is expected to grow at a CAGR of 9.6% from 2022 to 2028.
Increase in Prevalence of Blood Disorders is Driving the North America Blood Plasma Derivatives Market
According to the National Organizations of Rare Disorders, hemophilia A is a common X-linked recessive disorder and the second most common inherited clotting factor deficiency after von Willebrand disease. According to the National Library of Medicine (NLM), ~30,000–33,000 males were affected by hemophilia in the US in 2020. In the US, ~1 in 5,000 newborn males suffers from hemophilia A. According to National Organization for Rare Disorders, in 2022, immune thrombocytopenia (ITP), an autoimmune bleeding disorder, affects ~66 adults per 1 million in the US. Moreover, in the country, the incidence of ITP in adults is ~3.3 per 100,000/year, while the prevalence is 9.5 per 100,000. Furthermore, according to the US Department of Health & Human Services, in 2020, ~100,000 Americans had sickle cell disease (SCD), the most inherited blood disorder. Furthermore, by 2050, the number of SCD cases is expected to grow by ~30%. Hence, Plasma is a liquid portion of blood containing WBC and platelets. Blood plasma derivatives play a major role in stopping bleeding after an injury. Thus, the increasing prevalence of blood disorders across the world is one of the major driving factors promoting the growth of the blood plasma derivatives market growth.
North America Blood Plasma Derivatives Market Overview
The North America blood plasma derivatives market has been segmented into the US, Canada, and Mexico. US is expected to account for the largest market share. The prevalence of severe diseases, including hemophilia and immune deficiency disorders, is a main factor driving the market for blood plasma derivatives. According to the Centers for Disease Control and Prevention (CDC) data, Hemophilia A affects 1 in 5,000 male births. About 400 babies are born with hemophilia A each year. The exact number of people living with hemophilia in the US is unknown. Based on a recent study that used data collected on patients receiving care in federally funded hemophilia treatment centers during the period 2012-2018, as many as 33,000 males in the US are living with the disorder.
Furthermore, as per World Health Organization (WHO), out of 250,000 individuals diagnosed with PID (primary immune deficiencies) in the US in 2017, roughly 125,000 get month-to-month mixtures of immunoglobulins. It is assessed that more than 300,000 patients get monthly-to-month immunoglobulins implantations for PID. The rise in chronic conditions and increasing demand for immunoglobulin drive the development of the blood plasma derivatives market.
Exhibit: North America Blood plasma derivatives Market Revenue and Forecast to 2028 (US$ Million)
North America Blood plasma derivatives Market Segmentation
The North America blood plasma derivatives market is segmented into type, application, end user, and country.
The North America blood plasma derivatives market, by type, is segmented into albumin, factor VIII, factor IX, immunoglobulin, hyperimmune globulin, and others. The immunoglobulins segment held a larger market share in 2022.
Based on application, the North America blood plasma derivatives market is divided into hemophilia, hypogammaglobulinemia, immunodeficiency diseases, von Willebrand disease, and other applications. The immunodeficiency diseases applications segment held the largest share of the market in 2022.
The blood plasma derivatives market, by end user, is segmented into hospitals, diagnostic laboratories, clinics, and other end users. The hospitals segment held the largest share of the market in 2022.
Based on country, the North America blood plasma derivatives market is segmented into the US, Canada, and Mexico. The US dominated the market in 2022.
Grifols SA; SK Plasma Co Ltd; Octapharma AG; Monobind Inc.; Intas Pharmaceuticals Ltd; Takeda Pharmaceutical Co Ltd; CSL Behring LLC; LFB SA; and Kedrion SpA are the leading companies operating in the North America blood plasma derivatives market.
Increase in Prevalence of Blood Disorders is Driving the North America Blood Plasma Derivatives Market
According to the National Organizations of Rare Disorders, hemophilia A is a common X-linked recessive disorder and the second most common inherited clotting factor deficiency after von Willebrand disease. According to the National Library of Medicine (NLM), ~30,000–33,000 males were affected by hemophilia in the US in 2020. In the US, ~1 in 5,000 newborn males suffers from hemophilia A. According to National Organization for Rare Disorders, in 2022, immune thrombocytopenia (ITP), an autoimmune bleeding disorder, affects ~66 adults per 1 million in the US. Moreover, in the country, the incidence of ITP in adults is ~3.3 per 100,000/year, while the prevalence is 9.5 per 100,000. Furthermore, according to the US Department of Health & Human Services, in 2020, ~100,000 Americans had sickle cell disease (SCD), the most inherited blood disorder. Furthermore, by 2050, the number of SCD cases is expected to grow by ~30%. Hence, Plasma is a liquid portion of blood containing WBC and platelets. Blood plasma derivatives play a major role in stopping bleeding after an injury. Thus, the increasing prevalence of blood disorders across the world is one of the major driving factors promoting the growth of the blood plasma derivatives market growth.
North America Blood Plasma Derivatives Market Overview
The North America blood plasma derivatives market has been segmented into the US, Canada, and Mexico. US is expected to account for the largest market share. The prevalence of severe diseases, including hemophilia and immune deficiency disorders, is a main factor driving the market for blood plasma derivatives. According to the Centers for Disease Control and Prevention (CDC) data, Hemophilia A affects 1 in 5,000 male births. About 400 babies are born with hemophilia A each year. The exact number of people living with hemophilia in the US is unknown. Based on a recent study that used data collected on patients receiving care in federally funded hemophilia treatment centers during the period 2012-2018, as many as 33,000 males in the US are living with the disorder.
Furthermore, as per World Health Organization (WHO), out of 250,000 individuals diagnosed with PID (primary immune deficiencies) in the US in 2017, roughly 125,000 get month-to-month mixtures of immunoglobulins. It is assessed that more than 300,000 patients get monthly-to-month immunoglobulins implantations for PID. The rise in chronic conditions and increasing demand for immunoglobulin drive the development of the blood plasma derivatives market.
Exhibit: North America Blood plasma derivatives Market Revenue and Forecast to 2028 (US$ Million)
North America Blood plasma derivatives Market Segmentation
The North America blood plasma derivatives market is segmented into type, application, end user, and country.
The North America blood plasma derivatives market, by type, is segmented into albumin, factor VIII, factor IX, immunoglobulin, hyperimmune globulin, and others. The immunoglobulins segment held a larger market share in 2022.
Based on application, the North America blood plasma derivatives market is divided into hemophilia, hypogammaglobulinemia, immunodeficiency diseases, von Willebrand disease, and other applications. The immunodeficiency diseases applications segment held the largest share of the market in 2022.
The blood plasma derivatives market, by end user, is segmented into hospitals, diagnostic laboratories, clinics, and other end users. The hospitals segment held the largest share of the market in 2022.
Based on country, the North America blood plasma derivatives market is segmented into the US, Canada, and Mexico. The US dominated the market in 2022.
Grifols SA; SK Plasma Co Ltd; Octapharma AG; Monobind Inc.; Intas Pharmaceuticals Ltd; Takeda Pharmaceutical Co Ltd; CSL Behring LLC; LFB SA; and Kedrion SpA are the leading companies operating in the North America blood plasma derivatives market.
1. INTRODUCTION
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Blood Plasma Derivatives Market – by Type
1.3.2 North America Blood Plasma Derivatives Market – by Application
1.3.3 North America Blood Plasma Derivatives Market – by End User
1.3.4 North America Blood Plasma Derivatives Market – by Country
2. NORTH AMERICA BLOOD PLASMA DERIVATIVES MARKET – KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. NORTH AMERICA BLOOD PLASMA DERIVATIVES MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 North America PEST Analysis
4.2.1 Expert’s Opinion
5. NORTH AMERICA BLOOD PLASMA DERIVATIVES MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Increase in Prevalence of Blood Disorders
5.1.2 Rise in Geriatric Population
5.2 Market Restraints
5.2.1 Complicated Reimbursement Policies
5.3 Market Opportunities
5.3.1 Incorporation of Platelet-Rich Plasma in Regenerative Medicine
5.4 Future Trends
5.4.1 Increasing Usage of Immunoglobulin G in Multiple Treatments
5.5 Impact Analysis
6. BLOOD PLASMA DERIVATIVES MARKET – NORTH AMERICA ANALYSIS
6.1 North America: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7. NORTH AMERICA BLOOD PLASMA DERIVATIVES MARKET – REVENUE AND FORECAST TO 2028 – BY TYPE
7.1 Overview
7.2 North America Blood Plasma Derivatives Market Revenue Share, by Type 2021 & 2028 (%)
7.3 Albumin
7.3.1 Overview
7.3.2 Albumin: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Factor VIII
7.4.1 Overview
7.4.2 Factor VIII: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Factor IX
7.5.1 Overview
7.5.2 Factor IX: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Immunoglobulin
7.6.1 Overview
7.6.2 Immunoglobulin: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.3 IgG
7.6.3.1 Overview
7.6.3.2 IgG: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.4 IgM
7.6.4.1 Overview
7.6.4.2 IgM: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.5 IgA
7.6.5.1 Overview
7.6.5.2 IgA: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.6 IgD
7.6.6.1 Overview
7.6.6.2 IgD: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.7 IgE
7.6.7.1 Overview
7.6.7.2 IgE: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Hyperimmune Globulin
7.7.1 Overview
7.7.2 Hyperimmune Globulin: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8. NORTH AMERICA BLOOD PLASMA DERIVATIVES MARKET ANALYSIS AND FORECASTS TO 2028 – BY APPLICATION
8.1 Overview
8.2 North America Blood Plasma Derivatives Market, by Application 2021 & 2028 (%)
8.3 Hemophilia
8.3.1 Overview
8.3.2 Hemophilia: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Hypogammaglobulinemia
8.4.1 Overview
8.4.2 Hypogammaglobulinemia: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Immunodeficiency Diseases
8.5.1 Overview
8.5.2 Immunodeficiency Diseases: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Von Willebrand Disease
8.6.1 Overview
8.6.2 Von Willebrand Disease: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Other Applications
8.7.1 Overview
8.7.2 Other Applications: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
9. NORTH AMERICA BLOOD PLASMA DERIVATIVES MARKET – REVENUE AND FORECAST TO 2028 – BY END USER
9.1 Overview
9.2 North America Blood Plasma Derivatives Market Revenue Share, by End User 2021 & 2028 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Clinics
9.4.1 Overview
9.4.2 Clinics: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Other End Users
9.5.1 Overview
9.5.2 Other End Users: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10. NORTH AMERICA BLOOD PLASMA DERIVATIVES MARKET – REVENUE AND FORECAST TO 2028 – COUNTRY ANALYSIS
10.1 Overview
10.1.1 North America: Blood Plasma Derivatives Market, by Country, 2021 & 2028 (%)
10.1.1.1 US: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 US: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 US: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.1.1.1.3.1 US: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.1.1.1.4 US: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.1.1.1.5 US Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
10.1.1.2 Canada: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Canada: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 Canada: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.1.1.2.3.1 Canada: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.1.1.2.4 Canada: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.1.1.2.5 Canada Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
10.1.1.3 Mexico: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 Mexico: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 Mexico: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.1.1.3.3.1 Mexico: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.1.1.3.4 Mexico: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.1.1.3.5 Mexico Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
11. INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies in the Blood Plasma Derivatives Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. COMPANY PROFILES
12.1 Grifols SA
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 SK Plasma Co Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Octapharma AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Monobind Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Intas Pharmaceuticals Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Takeda Pharmaceutical Co Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 CSL Behring LLC
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 LFB SA
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Kedrion SpA
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Blood Plasma Derivatives Market – by Type
1.3.2 North America Blood Plasma Derivatives Market – by Application
1.3.3 North America Blood Plasma Derivatives Market – by End User
1.3.4 North America Blood Plasma Derivatives Market – by Country
2. NORTH AMERICA BLOOD PLASMA DERIVATIVES MARKET – KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. NORTH AMERICA BLOOD PLASMA DERIVATIVES MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 North America PEST Analysis
4.2.1 Expert’s Opinion
5. NORTH AMERICA BLOOD PLASMA DERIVATIVES MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Increase in Prevalence of Blood Disorders
5.1.2 Rise in Geriatric Population
5.2 Market Restraints
5.2.1 Complicated Reimbursement Policies
5.3 Market Opportunities
5.3.1 Incorporation of Platelet-Rich Plasma in Regenerative Medicine
5.4 Future Trends
5.4.1 Increasing Usage of Immunoglobulin G in Multiple Treatments
5.5 Impact Analysis
6. BLOOD PLASMA DERIVATIVES MARKET – NORTH AMERICA ANALYSIS
6.1 North America: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7. NORTH AMERICA BLOOD PLASMA DERIVATIVES MARKET – REVENUE AND FORECAST TO 2028 – BY TYPE
7.1 Overview
7.2 North America Blood Plasma Derivatives Market Revenue Share, by Type 2021 & 2028 (%)
7.3 Albumin
7.3.1 Overview
7.3.2 Albumin: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Factor VIII
7.4.1 Overview
7.4.2 Factor VIII: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Factor IX
7.5.1 Overview
7.5.2 Factor IX: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Immunoglobulin
7.6.1 Overview
7.6.2 Immunoglobulin: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.3 IgG
7.6.3.1 Overview
7.6.3.2 IgG: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.4 IgM
7.6.4.1 Overview
7.6.4.2 IgM: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.5 IgA
7.6.5.1 Overview
7.6.5.2 IgA: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.6 IgD
7.6.6.1 Overview
7.6.6.2 IgD: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.7 IgE
7.6.7.1 Overview
7.6.7.2 IgE: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Hyperimmune Globulin
7.7.1 Overview
7.7.2 Hyperimmune Globulin: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8. NORTH AMERICA BLOOD PLASMA DERIVATIVES MARKET ANALYSIS AND FORECASTS TO 2028 – BY APPLICATION
8.1 Overview
8.2 North America Blood Plasma Derivatives Market, by Application 2021 & 2028 (%)
8.3 Hemophilia
8.3.1 Overview
8.3.2 Hemophilia: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Hypogammaglobulinemia
8.4.1 Overview
8.4.2 Hypogammaglobulinemia: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Immunodeficiency Diseases
8.5.1 Overview
8.5.2 Immunodeficiency Diseases: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Von Willebrand Disease
8.6.1 Overview
8.6.2 Von Willebrand Disease: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Other Applications
8.7.1 Overview
8.7.2 Other Applications: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
9. NORTH AMERICA BLOOD PLASMA DERIVATIVES MARKET – REVENUE AND FORECAST TO 2028 – BY END USER
9.1 Overview
9.2 North America Blood Plasma Derivatives Market Revenue Share, by End User 2021 & 2028 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Clinics
9.4.1 Overview
9.4.2 Clinics: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Other End Users
9.5.1 Overview
9.5.2 Other End Users: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10. NORTH AMERICA BLOOD PLASMA DERIVATIVES MARKET – REVENUE AND FORECAST TO 2028 – COUNTRY ANALYSIS
10.1 Overview
10.1.1 North America: Blood Plasma Derivatives Market, by Country, 2021 & 2028 (%)
10.1.1.1 US: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 US: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 US: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.1.1.1.3.1 US: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.1.1.1.4 US: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.1.1.1.5 US Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
10.1.1.2 Canada: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Canada: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 Canada: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.1.1.2.3.1 Canada: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.1.1.2.4 Canada: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.1.1.2.5 Canada Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
10.1.1.3 Mexico: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 Mexico: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 Mexico: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.1.1.3.3.1 Mexico: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.1.1.3.4 Mexico: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.1.1.3.5 Mexico Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
11. INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies in the Blood Plasma Derivatives Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. COMPANY PROFILES
12.1 Grifols SA
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 SK Plasma Co Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Octapharma AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Monobind Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Intas Pharmaceuticals Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Takeda Pharmaceutical Co Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 CSL Behring LLC
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 LFB SA
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Kedrion SpA
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. US Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. US Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 3. US Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 4. US Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 5. Canada Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 6. Canada Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 7. Canada Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 8. Canada Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 9. Mexico Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 10. Mexico Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 11. Mexico Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 12. Mexico Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 13. Recent Inorganic Growth Strategies in the Blood Plasma Derivatives Market
Table 14. Recent Organic Growth Strategies in the Blood Plasma Derivatives Market
Table 15. Glossary of Terms
Table 1. US Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. US Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 3. US Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 4. US Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 5. Canada Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 6. Canada Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 7. Canada Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 8. Canada Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 9. Mexico Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 10. Mexico Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 11. Mexico Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 12. Mexico Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 13. Recent Inorganic Growth Strategies in the Blood Plasma Derivatives Market
Table 14. Recent Organic Growth Strategies in the Blood Plasma Derivatives Market
Table 15. Glossary of Terms
LIST OF FIGURES
Figure 1. North America Blood Plasma Derivatives Market Segmentation
Figure 2. North America Blood Plasma Derivatives Market, by Country
Figure 3. North America Blood Plasma Derivatives Market Overview
Figure 4. Immunoglobulin Segment Held Largest Share of Type Segment in North America Blood Plasma Derivatives Market
Figure 5. US is Expected to Show Remarkable Growth During Forecast Period
Figure 6. North America: PEST Analysis
Figure 7. Experts’ Opinion
Figure 8. North America Blood Plasma Derivatives Market: Impact Analysis of Drivers and Restraints
Figure 9. North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. North America Blood Plasma Derivatives Market Revenue Share, by Type 2021 & 2028 (%)
Figure 11. Albumin: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Factor VIII: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Factor IX: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Immunoglobulin: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. IgG: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. IgM: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. IgA: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. IgD: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. IgE: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Hyperimmune Globulin: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Others: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. North America Blood Plasma Derivatives Market, by Application 2021 & 2028 (%)
Figure 23. Hemophilia: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Hypogammaglobulinemia: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Immunodeficiency Diseases: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Von Willebrand Disease: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Other Applications: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. North America Blood Plasma Derivatives Market Revenue Share, by End User 2021 & 2028 (%)
Figure 29. Hospitals: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Clinics: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Other End Users: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. North America: Blood Plasma Derivatives Market, by Key Country – Revenue (2021) (US$ Million)
Figure 33. US: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Canada: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Mexico: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Growth Strategies in the Blood Plasma Derivatives Market
Figure 1. North America Blood Plasma Derivatives Market Segmentation
Figure 2. North America Blood Plasma Derivatives Market, by Country
Figure 3. North America Blood Plasma Derivatives Market Overview
Figure 4. Immunoglobulin Segment Held Largest Share of Type Segment in North America Blood Plasma Derivatives Market
Figure 5. US is Expected to Show Remarkable Growth During Forecast Period
Figure 6. North America: PEST Analysis
Figure 7. Experts’ Opinion
Figure 8. North America Blood Plasma Derivatives Market: Impact Analysis of Drivers and Restraints
Figure 9. North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. North America Blood Plasma Derivatives Market Revenue Share, by Type 2021 & 2028 (%)
Figure 11. Albumin: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Factor VIII: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Factor IX: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Immunoglobulin: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. IgG: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. IgM: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. IgA: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. IgD: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. IgE: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Hyperimmune Globulin: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Others: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. North America Blood Plasma Derivatives Market, by Application 2021 & 2028 (%)
Figure 23. Hemophilia: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Hypogammaglobulinemia: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Immunodeficiency Diseases: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Von Willebrand Disease: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Other Applications: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. North America Blood Plasma Derivatives Market Revenue Share, by End User 2021 & 2028 (%)
Figure 29. Hospitals: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Clinics: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Other End Users: North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. North America: Blood Plasma Derivatives Market, by Key Country – Revenue (2021) (US$ Million)
Figure 33. US: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Canada: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Mexico: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Growth Strategies in the Blood Plasma Derivatives Market
